TIOSALIS®

Ondansetron package with 1 vial containing 8 mg / 4 ml.

Therapeutic action:

Antiemetic agent.

Presentation:

Package with 1 vial containing

8 mg / 4 ml.

Indications:

Chemotherapy induced nausea and vomiting.

Dosage and administration:

TIOSALIS® is administered in slow intravenously injection or perfusion, 8 mg over 15 minutes, before chemotherapy, follow by continuous perfusion of

1 ml/hour, until 24 hours, or two perfusion of 8 mg in 15 minutes each 4 hours.

Conservation:

Storage at room temperature

(15°C – 30°C) protected from the light.